Vision 20 ingredients: a dose-by-dose audit against the trials
After 50 Strong checked every ingredient Vision 20 names against the human trials its category relies on. The audit lands in three piles. The carotenoid core, lutein and zeaxanthin, matches the AREDS2 doses in some label versions: genuinely dosed right. Zinc sits in a version conflict that must be resolved on your own bottle. And the botanical section, ginkgo, bilberry, pine bark and lycopene, carries no macular-degeneration evidence at all: filler by the only standard that matters, human trials. Here is each ingredient, its studied dose, and its verdict.
- Dosed right: lutein 10 mg plus zeaxanthin 2 mg, if that is what your bottle says. That is the AREDS2 pair tested in 4,203 participants.
- Cannot verify: zinc. Versions range from unlisted to 50 mg, above the NIH tolerable upper intake of 40 mg per day.
- Filler by eye evidence: ginkgo biloba, bilberry, maritime pine bark and lycopene. No AMD trials.
- Missing: the AREDS2 vitamin-mineral base, vitamin C 500 mg, vitamin E 400 IU, zinc 80 mg and copper 2 mg, has no confirmed equivalent here.
The dose audit
| Ingredient | Studied dose for eyes | Vision 20 status | Verdict |
|---|---|---|---|
| Lutein | 10 mg per day in AREDS2, 4,203 participants with AMD | 10 mg in some versions, 20 mg in others | Dosed right at 10 mg; 20 mg is beyond the studied dose |
| Zeaxanthin | 2 mg per day in AREDS2 | 2 mg alongside lutein in matching versions | Dosed right where listed |
| Zinc (citrate) | 80 mg as oxide in AREDS2, deliberately paired with copper | Unlisted to 50 mg depending on version | Cannot verify; 50 mg would exceed the NIH 40 mg upper limit without copper pairing |
| Ginkgo biloba | No macular-degeneration trial defines a dose | Present, dose varies by version | Filler for eye purposes; the bleeding interaction is its only documented distinction |
| Bilberry | Rigorous RCTs tested standardized extracts; all four most recent were negative for night vision | Present, dose varies by version | Filler; failed its best trials |
| Maritime pine bark | No AMD trials | Present in some versions | Filler |
| Astaxanthin | 4 to 12 mg per day in small eye-fatigue trials | Present in some versions | Within studied range if 4 to 12 mg; the studied claim is screen fatigue, not macular health |
| Lycopene | No eye-outcome trials | Present in some versions | Filler for eye purposes |
| Vitamins A, C, E | AREDS2 used C 500 mg, E 400 IU; no vitamin A beyond carotenoids | Present in unconfirmed amounts | Cannot verify against AREDS2 |
Ingredient by ingredient: what the research actually says
Lutein and zeaxanthin: the reason to look at this bottle at all
These two carotenoids are the only Vision 20 ingredients with a human trial worth citing in their own right. AREDS2 randomized 4,203 participants with age-related macular degeneration to lutein 10 mg plus zeaxanthin 2 mg added to a vitamin-mineral base. The primary analysis did not reach statistical significance; secondary analyses suggested benefit for people with low dietary intake, and the 10-year follow-up supported that pattern. If your bottle says 10 mg and 2 mg, the headline pair matches the studied doses. Our lutein and zeaxanthin guide walks the trial in full.
Zinc: the arithmetic problem
AREDS2 used 80 mg of zinc, a deliberately pharmacological dose, and paired it with 2 mg of copper because chronic high zinc depletes copper. The NIH tolerable upper intake for adults is 40 mg per day. Vision 20’s zinc appears as citrate, a reasonable form, but the dose is unconfirmed across versions, and one widely copied listing shows 50 mg with no visible copper. Until the label on your bottle settles it, zinc is the ingredient that most needs a look.
The botanical section: label weight, trial weight
Ginkgo, bilberry, pine bark and lycopene give Vision 20 its ingredient-count marketing, and none of them carries a macular-degeneration trial. Bilberry is the instructive case: a systematic review of 12 placebo-controlled trials found the four most recent and rigorous all failed to show night-vision improvement in healthy people. Our bilberry guide covers that record. Astaxanthin is the one botanical with a foot in real research: small trials at 4 to 12 mg per day for screen-related eye fatigue, a different claim from macular protection.
What the label leaves out
The omissions are structural. AREDS2 is a specific five-part vitamin-mineral base plus two carotenoids. Vision 20 keeps the carotenoids and replaces the base with botanicals. That means no confirmed vitamin C 500 mg, no confirmed vitamin E 400 IU, no confirmed zinc 80 mg, and no copper 2 mg anywhere in the formula. Whether that matters depends on why you are buying: for general supplementation, the missing base is arguably fine. For anyone whose eye specialist recommended AREDS2 for diagnosed macular degeneration, Vision 20 is not that formula, and the difference is exactly these omissions.
The bottom line on the label
Audit result. Two ingredients earn a clean verdict where the label cooperates: lutein and zeaxanthin at AREDS2 doses. One needs arithmetic on your bottle: zinc. Four occupy the label without eye evidence: ginkgo, bilberry, pine bark, lycopene. And the AREDS2 base is absent by design. That makes Vision 20 a carotenoid supplement with botanical padding, not an AREDS2-style formula. For how that plays out in price and practice, see our full Vision 20 review; for the safety picture, the side effects guide.
Frequently Asked Questions
What are the active ingredients in Vision 20?
The core is a branded lutein-plus-zeaxanthin complex called LuteMax 2020, paired with zinc citrate. Around that sit botanicals including ginkgo biloba, bilberry and maritime pine bark, plus carotenoids such as lycopene and astaxanthin, and vitamins A, C and E, depending on the label version. Doses for the key actives appear in some materials, but versions circulating online disagree, so the only authoritative source is the bottle itself.
Is Vision 20 dosed like AREDS2?
Only on the carotenoids, and only if your bottle shows lutein 10 mg and zeaxanthin 2 mg, the doses AREDS2 tested in 4,203 participants. The rest of AREDS2 is missing from Vision 20: the vitamin-mineral base of vitamin C 500 mg, vitamin E 400 IU, zinc 80 mg and copper 2 mg has no confirmed equivalent on Vision 20 labels. Vision 20 borrows the best-known part of AREDS2 and replaces the rest with botanicals that have no macular-degeneration trials. Same headline nutrients, different formula, different evidence.
Which Vision 20 ingredients are filler?
By the human eye evidence, four ingredients qualify. Ginkgo biloba has no meaningful macular-degeneration trial record. Bilberry failed its four most rigorous randomized trials for night vision, per a systematic review of 12 placebo-controlled studies. Maritime pine bark has no AMD trials worth citing. Lycopene has antioxidant research but no eye-outcome trials. None are harmful at typical doses. They occupy label space and price weight without carrying eye evidence.
Why do different sources list different Vision 20 doses?
Because the versions genuinely differ. Some materials show lutein at 10 mg and others at 20 mg; one widely copied retail listing shows zinc at 50 mg. Formulas get revised over a product’s life, affiliate pages copy old labels, and marketplace listings add noise. The practical rule: ignore every screenshot, including ours, and read the Supplement Facts on the physical bottle or the exact checkout page you order from. Then compare against the AREDS2 reference doses.
What is LuteMax 2020?
A branded lutein-plus-zeaxanthin complex made from marigold extract, positioned for eye-health formulations. Branded complexes like this carry ingredient-level studies, which is what the clinically tested marketing language refers to. That ingredient-level research is real as far as it goes. It is not a trial of Vision 20, and it does not tell you the dose in your bottle, which is the number that matters against the AREDS2 reference of lutein 10 mg plus zeaxanthin 2 mg.
What is missing from Vision 20?
Three things. The AREDS2 vitamin-mineral base: no confirmed vitamin C 500 mg, vitamin E 400 IU, zinc 80 mg or copper 2 mg, the combination the 4,203-person trial actually tested. Copper specifically matters because high-dose zinc depletes it, which is why AREDS2 paired them. And disclosed doses for every ingredient, which versions disagree on. What a formula leaves out matters as much as what it contains, and here the omissions are the difference between an AREDS2-style product and a carotenoid-plus-botanical blend.
